GIMAP2 Inhibitors
GIMAP2 inhibitors are a class of chemical compounds specifically designed to interfere with the function of GIMAP2, a protein implicated in various cellular processes. These inhibitors work by binding to the GIMAP2 protein or its associated molecular partners, thereby obstructing its normal activity. The exact mechanism of inhibition can vary among different chemicals within this class but typically involves either blocking the active site of the protein or altering its conformation in such a way that its functional capacity is diminished. The binding of these inhibitors is typically highly specific, ensuring that GIMAP2's activity is selectively targeted without affecting similar proteins in the cell. This specificity is crucial for the desired inhibition and reduces the likelihood of off-target effects that could disrupt other cellular functions.
The development of GIMAP2 inhibitors is based on a thorough understanding of the protein's structure and the pathways it is involved in. By analyzing the three-dimensional conformation of GIMAP2, scientists can identify potential binding sites for inhibitors and design molecules that fit precisely into these sites. These inhibitors often mimic the natural substrates or ligands of the protein, taking advantage of the same interactions that GIMAP2 would typically engage in during its normal operation. Once bound, these inhibitors may induce a conformational change in GIMAP2, which can prevent it from adopting the necessary structure for its activity. Alternatively, they may simply occupy the active site or a critical region of the protein, preventing access to the substrates or other molecules required for its function. The end result is a decrease in GIMAP2 activity, which can have downstream effects on the signaling pathways and cellular processes in which GIMAP2 participates. The precise biochemical pathways affected would depend on the role of GIMAP2 within the cell, which could involve immune response regulation, apoptosis, or other cellular maintenance mechanisms.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A potent inhibitor of PI3K, LY294002 leads to the inhibition of the PI3K/AKT pathway, which is crucial for the survival of many cells. Inhibition of this pathway can result in decreased cell survival and function, which may indirectly lead to reduced GIMAP2 activity, as GIMAP2 is involved in cellular survival and immune response regulation. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor that strongly suppresses the PI3K/AKT pathway. By doing so, it can negatively affect cell survival mechanisms that are potentially regulated by GIMAP2, given its role in immune cell regulation. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
As an mTOR inhibitor, Rapamycin disrupts mTORC1 signaling, which can downregulate protein synthesis and cell growth signals that may be important for GIMAP2's function in T-cell development and maintenance. | ||||||
PP242 | 1092351-67-1 | sc-301606A sc-301606 | 1 mg 5 mg | $57.00 $172.00 | 8 | |
PP242 is an mTOR kinase inhibitor, which, unlike Rapamycin, inhibits both mTORC1 and mTORC2 complexes. This can lead to a more complete inhibition of the mTOR pathway, potentially affecting GIMAP2's role in immune cell functions. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of c-Jun N-terminal kinase (JNK), Sp600125 can impact the JNK signaling pathway involved in apoptosis and cellular differentiation, which might indirectly affect GIMAP2's function in lymphocyte development and apoptosis. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor and by inhibiting p38 MAPK, it can interfere with inflammatory responses and cytokine production, processes in which GIMAP2 could be indirectly involved. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a MEK inhibitor which may indirectly affect GIMAP2 by inhibiting the ERK pathway, subsequently impacting the proliferation and survival of cells, including those where GIMAP2 is expressed. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is another MEK inhibitor that impairs the MAPK/ERK pathway. The disruption of this pathway can affect cell cycle progression and differentiation, which may in turn influence GIMAP2's role in immune cell regulation. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
An inhibitor of NF-κB activation, BAY 11-7082 prevents the translocation of NF-κB to the nucleus, thereby inhibiting inflammatory responses. GIMAP2, associated with immune cell survival, could be affected by changes in NF-κB activity. | ||||||
PI 3-Kγ Inhibitor | 648450-29-7 | sc-203191 | 5 mg | $76.00 | ||
AS605240 is a selective PI3Kγ inhibitor. By specifically targeting the gamma isoform of PI3K, it can influence neutrophil activity and other immune responses, potentially affecting GIMAP2's role in these processes. | ||||||